Skip to NavigationSkip to content

News

0
MSD’s anti-PD-1 therapy Keytruda has secured another approval from the FDA, this time as a first-line treatment in combination with Pfizer’s Inlyta...
0
Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s alleged...
0
Pfizer’s vice president and head of immune-oncology clinical development has joined Aduro Biotech as the company’s new Chief Medical Officer, just...
0
Patients with Parkinson’s have been able to walk after receiving electrical stimulation to their spines.

Features

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research...